Loading company
InMode Ltd.
INMD · Nasdaq · ·
Next earnings: November 4, 2026
$14.22+0.1%Sep 29 close
- 1M
- -5.4%
- 6M
- +3.8%
- 1Y
- -6.9%
- 5Y
- -83.4%
INMD · Nasdaq · ·
Next earnings: November 4, 2026
$14.22+0.1%Sep 29 close
InMode Ltd. is scheduled to report next on November 4, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $95.6M | $95.6M | -0.01% |
| Profit | $17.1M | $26.7M | -36.19% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
InMode Ltd. has no earnings call transcript available.
“Overall revenue was consistent with the prior-year period, and we saw continued stability in our U.S. capital equipment business, reflecting steady customer demand. This performance is consistent with the stabilization we anticipate will continue through the remainder of the year. We remain focused on investing in opportunities that support long-term growth,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency (“RF”) technology. InMode strives to enable emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from the 6-K InMode Ltd. filed on August 5, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.